July 25th 2018EP. 1: Combination Therapy: Improving Multiple Myeloma Outcomes
July 25th 2018EP. 2: Selecting Therapy for Newly Diagnosed Myeloma
July 25th 2018EP. 3: Newly Diagnosed Multiple Myeloma: Frontline Options
July 25th 2018EP. 4: Optimizing Treatment for MM: Transplant and Maintenance
July 25th 2018EP. 5: Multiple Myeloma: Approaching Treatment at First Relapse
July 25th 2018EP. 6: Incremental Changes in Therapy at MM Relapse
July 25th 2018EP. 7: Treating Multiple Myeloma Through Multiple Relapses
July 25th 2018EP. 8: Increasingly Improved Outcomes for Multiple Myeloma
July 25th 2018EP. 9: Considerations for Newly Diagnosed Multiple Myeloma
July 25th 2018EP. 10: Frontline Treatment Options for Multiple Myeloma
July 25th 2018EP. 11: Daratumumab's Potential as Frontline Therapy for MM
July 25th 2018EP. 12: Optimizing Frontline Therapy in Multiple Myeloma
July 25th 2018EP. 13: Treating Multiple Myeloma at First Relapse
July 25th 2018EP. 14: Treating Multiple Myeloma at Second Relapse and Beyond
July 25th 2018EP. 15: Advent of Combination Strategies in Multiple Myeloma
July 25th 2018EP. 16: Approaching Upfront Treatment for Multiple Myeloma
July 25th 2018EP. 17: Frontline Therapy Options for Multiple Myeloma
July 25th 2018EP. 18: Multiple Myeloma: Frontline Daratumumab Combinations
July 25th 2018EP. 19: Frontline Therapy's Impact on Later Treatment in MM
July 25th 2018EP. 20: Optimizing Maintenance Therapy in Multiple Myeloma
July 25th 2018EP. 21: Selecting Treatment at First Relapse of Multiple Myeloma
July 25th 2018EP. 22: Second Myeloma Relapse and Beyond: Upcoming Strategies
July 25th 2018EP. 23: Addressing Unmet Needs in Multiple Myeloma
